Keyword Connections

•  Alex Waterson
•  Antonis Hatzopoulos
•  Aron Parekh
•  Ashwath Jayagopal
•  BethAnn McLaughlin
•  Charles Hong
•  Chris Wright
•  Colleen Niswender
•  Corey Hopkins
•  Craig Lindsley

•  David Calkins
•  Edward Chaum
•  Edward Levine
•  Ethan Lee
•  Gurjeet Birdee
•  Hak-Joon Sung
•  Hui Zhou
•  James Goldenring
•  Javid Moslehi
•  Jialiang Wang

•  Jonathan Irish
•  Juan Colazo
•  Kaylon Bruner-Tran
•  Kevin Osteen
•  Kyle Emmitte
•  Lauren Woodard
•  Quinn Wells
•  Robert Macdonald
•  Scott Baldwin
•  Terri Ray

Resources

• No matching connections

Communities

• Baldwin Lab
• Center for Innovative Technology
• Goldenring Lab
• Hatzopoulos Lab
• Hong Lab
• Irish Lab
• Richmond Lab
• Sung Lab
• Wright Lab

Publications

• Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
  Lyman GH, Moses HL
  (2016) N Engl J Med 375: 4-6
• Pharmacogenomics: will the promise be fulfilled?
  Altman RB, Kroemer HK, McCarty CA, Ratain MJ, Roden D
  (2011) Nat Rev Genet 12: 69-73
• Building evidence and measuring clinical outcomes for genomic medicine.
  Peterson JF, Roden DM, Orlando LA, Ramirez AH, Mensah GA, Williams MS
  (2019) Lancet 394: 604-610
• Heart repair by reprogramming non-myocytes with cardiac transcription factors.
  Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN
  (2012) Nature 485: 599-604
• In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.
  Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA
  (2008) Nature 455: 627-32
• Standards for education and credentialing in critical care medicine.
  Kaplan LJ, Shaw AD
  (2011) JAMA 305: 296-7
• Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program.
  Rothman RL, DeWalt DA, Malone R, Bryant B, Shintani A, Crigler B, Weinberger M, Pignone M
  (2004) JAMA 292: 1711-6
• Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
  Zhang B, Beeghly-Fadiel A, Long J, Zheng W
  (2011) Lancet Oncol 12: 477-88
• Anticancer therapy SMRT-ens up: targeting the BCL6-SMRT interaction in B cell lymphoma.
  Compton LA, Hiebert SW
  (2010) Cancer Cell 17: 315-6
• Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
  Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM
  (2004) J Clin Oncol 22: 4979-90
• Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
  Bellinger AM, Arteaga CL, Force T, Humphreys BD, Demetri GD, Druker BJ, Moslehi JJ
  (2015) Circulation 132: 2248-58
• Pharmacogenomics: personalizing pediatric heart transplantation.
  Van Driest SL, Webber SA
  (2015) Circulation 131: 503-12
• The Future of Cardiovascular Therapeutics.
  MacRae CA, Roden DM, Loscalzo J
  (2016) Circulation 133: 2610-7
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
  January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC/AHA Task Force Members
  (2014) Circulation 130: e199-267
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
  January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC/AHA Task Force Members
  (2014) Circulation 130: 2071-104
• Responding to the clopidogrel warning by the US food and drug administration: real life is complicated.
  Roden DM, Shuldiner AR
  (2010) Circulation 122: 445-8
• The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
  Kaufman HL, Kirkwood JM, Hodi FS, Agarwala S, Amatruda T, Bines SD, Clark JI, Curti B, Ernstoff MS, Gajewski T, Gonzalez R, Hyde LJ, Lawson D, Lotze M, Lutzky J, Margolin K, McDermott DF, Morton D, Pavlick A, Richards JM, Sharfman W, Sondak VK, Sosman J, Steel S, Tarhini A, Thompson JA, Titze J, Urba W, White R, Atkins MB
  (2013) Nat Rev Clin Oncol 10: 588-98
• Applied pharmacogenomics in cardiovascular medicine.
  Weeke P, Roden DM
  (2014) Annu Rev Med 65: 81-94
• Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.
  Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Wildiers H, Floris G, Schmidt MK, Rookus MA, van den Hurk K, de Kort WL, Couch FJ, Olson JE, Hallberg E, Vachon C, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Li J, Humphreys K, Brand J, Guénel P, Truong T, Cordina-Duverger E, Menegaux F, Burwinkel B, Marme F, Yang R, Surowy H, Benitez J, Zamora MP, Perez JI, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Chenevix-Trench G, kConFab Investigators, Australian Ovarian Study Group, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Lindblom A, Margolin S, Hooning MJ, Martens JW, Tilanus-Linthorst MM, Collée JM, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow AJ, Ashworth A, Orr N, Jones M, Figueroa J, Garcia-Closas M, Brinton L, Lissowska J, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Brüning T, Ko YD, Peterlongo P, Manoukian S, Bonanni B, Radice P, Bogdanova N, Antonenkova N, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubiński J, Jaworska-Bieniek K, Durda K, Hamann U, Torres D, Schmutzler RK, Neuhausen SL, Anton-Culver H, Kristensen VN, Grenaker Alnæs GI, DRIVE Project, Pierce BL, Kraft P, Peters U, Lindstrom S, Seminara D, Burgess S, Ahsan H, Whittemore AS, John EM, Gammon MD, Malone KE, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Pharoah PD, Simard J, Hall P, Hunter DJ, Easton DF, Zheng W
  (2015) J Natl Cancer Inst 107:
• Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it?
  Stack JP, Moslehi J, Sayed N, Wu JC
  (2019) Eur Heart J 40: 1764-1770
• National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline.
  Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M
  (2010) Ann Intern Med 153: 176-81
• MiRNA inhibition in tissue engineering and regenerative medicine.
  Beavers KR, Nelson CE, Duvall CL
  (2015) Adv Drug Deliv Rev 88: 123-37
• Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
  Wang J, Mouradov D, Wang X, Jorissen RN, Chambers MC, Zimmerman LJ, Vasaikar S, Love CG, Li S, Lowes K, Leuchowius KJ, Jousset H, Weinstock J, Yau C, Mariadason J, Shi Z, Ban Y, Chen X, Coffey RJC, Slebos RJC, Burgess AW, Liebler DC, Zhang B, Sieber OM
  (2017) Gastroenterology 153: 1082-1095
• Cardiovascular pharmacogenomics.
  Roden DM, Johnson JA, Kimmel SE, Krauss RM, Medina MW, Shuldiner A, Wilke RA
  (2011) Circ Res 109: 807-20
• Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
  Roden DM, Van Driest SL, Wells QS, Mosley JD, Denny JC, Peterson JF
  (2018) Circ Res 122: 1176-1190
• Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.
  Austin ED, West J, Loyd JE, Hemnes AR
  (2017) Am J Respir Crit Care Med 195: 23-31
• Global implementation of genomic medicine: We are not alone.
  Manolio TA, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger AC, Bleyl S, Chakravarti A, Chantratita W, Chisholm RL, Dissanayake VH, Dunn M, Dzau VJ, Han BG, Hubbard T, Kolbe A, Korf B, Kubo M, Lasko P, Leego E, Mahasirimongkol S, Majumdar PP, Matthijs G, McLeod HL, Metspalu A, Meulien P, Miyano S, Naparstek Y, O'Rourke PP, Patrinos GP, Rehm HL, Relling MV, Rennert G, Rodriguez LL, Roden DM, Shuldiner AR, Sinha S, Tan P, Ulfendahl M, Ward R, Williams MS, Wong JE, Green ED, Ginsburg GS
  (2015) Sci Transl Med 7: 290ps13
• Genetic mechanisms of atrial fibrillation: impact on response to treatment.
  Darbar D, Roden DM
  (2013) Nat Rev Cardiol 10: 317-29
• Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.
  Iams WT, Lovly CM
  (2018) Cancer Discov 8: 797-799
• Anonymization of electronic medical records for validating genome-wide association studies.
  Loukides G, Gkoulalas-Divanis A, Malin B
  (2010) Proc Natl Acad Sci U S A 107: 7898-903
• Phenome-Wide Association Studies as a Tool to Advance Precision Medicine.
  Denny JC, Bastarache L, Roden DM
  (2016) Annu Rev Genomics Hum Genet 17: 353-73
• Insights into severe sepsis in older patients: from epidemiology to evidence-based management.
  Girard TD, Opal SM, Ely EW
  (2005) Clin Infect Dis 40: 719-27
• Vaginal douching: evidence for risks or benefits to women's health.
  Martino JL, Vermund SH
  (2002) Epidemiol Rev 24: 109-24
• Impact of genomics on personalized cancer medicine.
  Arteaga CL, Baselga J
  (2012) Clin Cancer Res 18: 612-8
• Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine.
  Katayama R, Lovly CM, Shaw AT
  (2015) Clin Cancer Res 21: 2227-35
• Established, emerging and elusive molecular targets in the treatment of lung cancer.
  Gallant JN, Lovly CM
  (2018) J Pathol 244: 565-577
• Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.
  Lehmann BD, Pietenpol JA
  (2014) J Pathol 232: 142-50
• ACG clinical guideline: diagnosis and management of achalasia.
  Vaezi MF, Pandolfino JE, Vela MF
  (2013) Am J Gastroenterol 108: 1238-49; quiz 1250